Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, and Nonmelanoma Skin Cancer Studies.
Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆
In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
Predictors of long‐term drug survival for infliximab in psoriasis